Drug Type Small molecule drug |
Synonyms PSYLO 5001, PSYLO5001 |
Target |
Action agonists |
Mechanism 5-HT2A receptor agonists(Serotonin 2a (5-HT2a) receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Psychotic Disorders | Preclinical | United States | 16 Feb 2025 |